Learn more
Log in
0 followers
Visus Therapeutics is a clinical-stage company in pursuit of developing the world’s first presbyopia-correcting eye drop with the potential to last at least eight hours.
Industries
Headquarters
Stage
Employees
Links
Ben Bergo
9 members
4 members
BioTeam
2 followers
PostEra
1 follower
Thermo Fisher Scientific
110 followers
Agilent Technologies
60 followers
Guardant Health
9 followers
Discover companies